share_log
Reuters ·  May 3 06:42
Neurocrine Biosciences Inc : Citigroup Raises Target Price to $150 From $140
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment